Sif's Revenue Nearly Doubled-But a €40M Push to 2027 Turns This Into a Make-or-Break Story

Sif's H1 2026 improvement is real, but 2027 is still the make-or-break test

Sif's first-half results show an operating business that is turning a corner. The company reported 93% revenue growth to €498.4 million and adjusted EBITDA up 236% to €43.4 million in the first half. At the same time, Sif still carried a trailing 12-month loss of €34.7 million. That combination is the whole setup: the factory is improving, but the company is not out of the danger zone yet.

The key issue is no longer whether Sif can produce. It is whether the 2027 plan holds together long enough for the first-half progress to matter. Management moved €40 million adjusted EBITDA and related revenues from 2026 to 2027 to preserve workforce continuity, while the 190 kton exclusive project for 2027 remains the main bridge to stability. If that project materialises, the story can improve quickly. If it does not, investors will likely refocus on funding risk and execution pressure.

Factory output is improving, but execution and funding still need clarity

Production is no longer the weak point

If you look at physical output, Sif is clearly further along the ramp-up. The plants delivered 101 monopiles and 141 kton in the first half, while leadership said Maasvlakte 2 and Roermond achieving stable output of 4-5 monopiles per week. Health and safety metrics also improved, with declining sick leave and reduced serious injuries. Taken together, that suggests the sites are becoming more stable and easier to run.

Better output still came with costs

Operational progress has not fully translated into clean economics. Sif also recorded €19M in liquidated damages in the first half. That does not cancel out the improvement, but it does show the business still has execution issues to clear up.

Funding remains the tighter constraint. Reporting on the earnings context, investing.com said liquidity stands at €60M with current ratio of 0.49 and that the company postponed bond issue due to unattractive pricing and unsigned project status. In other words, the company has some room to manoeuvre, but not much spare capacity if 2027 slips.

What the stock needs from 2027 to work

The next move in the stock depends less on whether Sif can keep producing and more on whether the 2027 plan starts to look achievable.

The market is pricing a bridge, not a completed turnaround

Sif has already shifted €40 million adjusted EBITDA and related revenues from 2026 to 2027 to keep the workforce intact. Management is now leaning on the 190 kton exclusive project for 2027 to make that bridge work. That is the core investment question: is this a temporary bridge into better times, or a holding pattern that ends in downsizing?

The bullish path is straightforward. If the 190 kton project is secured and production keeps improving, Sif has a credible case for stabilising the business and rebuilding margins over time.

The bearish path is just as clear. Management has warned that if the 190 kton project does not materialize, significant downsizing and mothballing of facilities would be required. If that project remains unsigned, the stock becomes a timing trade rather than a recovery story.

What to watch next

The most important near-term signals are simple:

• Whether the 190 kton 2027 project moves from exclusive discussions to a firm award
• Whether Sif can avoid further liquidated damages after the €19M in liquidated damages reported in the first half
• Whether liquidity stays sufficient while the company waits for that catalyst, given the liquidity stands at €60M with current ratio of 0.49

Sif also said it is shortlisted for most active tenders for 2028-2029, which is encouraging for the longer term. For now, though, the stock still needs 2027 to work first.

What would invalidate the bull case?

The cleanest invalidation signal is straightforward: continued delays on the 2027 project, more talk about cuts or mothballing, or another quarter without clear progress on securing the bridge. If that happens, the market will likely stop treating Sif as a recovery story and start treating it as a restructuring risk.